Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder

Journal of Urology

Volumn 155, Issue 5, 1996, Pages 1754-1757

  Glick, Seth H ^a   Howell, Lydia P ^a   Devere White, Ralph W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bladder neoplasms; genes, p53; immunohistochemistry; oncogene proteins

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0029991495     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66192-5     Document Type: Article

References (19)

1. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C. and Wahl, G. M.: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937, 1992.
2. Hupp, T. R., Meek, D. W., Midgeley, C. A. and Lane, D. P.: Regulation of the specific DNA binding function of p53. Cell, 71: 875, 1992.
3. Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M. and Levine, A. J.: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol., 8: 531, 1988.
4. Esrig, D., Spruck, C. H., Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. G., Skinner, D. G., Jones, P. A. and Cote, R. J.: p53 nuclear protein accumulation correlates with mutation in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol., 143: 1389, 1993.
5. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Zhang, Z., Sheinfeld, J., Fair, W., Herr, H. H. and Reuter, V. E.: Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J. Natl. Cancer Inst., 85: 53, 1993.
6. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Melamed, J., Zhang, Z., Sheinfeld, J., Fair, W. R., Herr, H. H. and Reuter, V. E.: Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J. Urol., 152: 388, 1994.
7. Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S. C., Nichols, P. W., Skinner, D. G., Jones, P. A. and Cote, R. J.: Accumulation of nuclear p53 and tumor progression in bladder cancer. N. Engl. J. Med., 331: 1259, 1994.
8. Lipponen, P. K.: Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int. J. Cancer, 53: 365, 1993.
9. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. and Korsmeyer, S. J.: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348: 334, 1990.
10. Ngan, B.-Y., Chen-Levy, Z., Weiss, L. M., Warnke, R. A. and Cleary, M. L.: Expression in non-Hodgkin lymphoma of the bcl-2 protein associated with the t(14;18) translocation. N. Engl. J. Med., 318: 1638, 1988.
11. Nunez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J. P. and Korsmeyer, S. J.: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor deprived hematopoietic cell lines. J. Immunol., 144: 3602, 1990.
12. Miyashita, T. and Reed, J. C.: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151, 1993.
13. Ryan, J. J., Prochownik, E., Gottlieb, C. A., Apel, I. J., Merino, R., Nunez, G. and Clarke, M. F.: c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc. Natl. Acad. Sci. U.S.A., 91: 5878, 1994.
14. Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M. and Korsmeyer, S. J.: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A., 88: 6961, 1991.
15. Daas, M., del Rosario, A. D., Bui, H. X., Singh, J. K. and Ross, J. S.: Bcl-2 protein expression is related to cellular differentiation in urinary bladder transitional cell carcinoma (UB-TCC). Presented at U.S. and Canadian Academy of Pathology, Toronto, 1995.
16. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457, 1958.
17. Tribukait, B. and Eposti, P.: Quantitative flow-microfluorometric analysis of the DNA in cells from neoplasms of the urinary bladder: correlation of aneuploidy with histological grading and the cytological findings. Urol. Res., 6: 201, 1978.
18. Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P. and Vogelstein, B.: Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252: 706, 1991.
19. Cordon-Cardo, C., Dalbagni, G., Saez, G. T., Oliva, M. R., Zhang, Z., Rosai, J., Reuter, V. E. and Pellicer, A.: p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int. J. Cancer, 56: 347, 1994.